SSGJ-601 versus Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion: 52-Week Results from a Phase 3 Study.

Wang L, Li Z, Ren X, Tan L, Zhao S, Lu Y, Hao J, Wu M, Xu X, Shi H, Ren Q, You Z, Song Y, Zhang W, Lei C, Zhang X, Wang X, Tan W, Yuan S, Tao L, Chen C, Song Z, Zhuang W, Zhang H, Han Q, Jin Y, Peng J, Zhang Q, Gao J, Pan X, Shen Y, Li M, Wang J, An L, Liu X, Li J, Chen L, Wang H, Zhang J, Zhou Z, Zhong J, Wang Y, Zhang T, Xiong W, Cui L, Peng X, Yang M, Zhang M, Li Z, Wang H, Lou J, Liu Y, Dai H, Li X

Open source

DOI: 10.1016/j.oret.2026.08.025
Published: 2026 Aug 31
Container: Ophthalmology. Retina
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.oret.2026.08.025,
  title = {SSGJ-601 versus Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion: 52-Week Results from a Phase 3 Study.},
  author = {Wang L and Li Z and Ren X and Tan L and Zhao S and Lu Y and Hao J and Wu M and Xu X and Shi H and Ren Q and You Z and Song Y and Zhang W and Lei C and Zhang X and Wang X and Tan W and Yuan S and Tao L and Chen C and Song Z and Zhuang W and Zhang H and Han Q and Jin Y and Peng J and Zhang Q and Gao J and Pan X and Shen Y and Li M and Wang J and An L and Liu X and Li J and Chen L and Wang H and Zhang J and Zhou Z and Zhong J and Wang Y and Zhang T and Xiong W and Cui L and Peng X and Yang M and Zhang M and Li Z and Wang H and Lou J and Liu Y and Dai H and Li X},
  year = {2026},
  journal = {Ophthalmology. Retina},
  doi = {10.1016/j.oret.2026.08.025},
  url = {https://doi.org/10.1016/j.oret.2026.08.025}
}

RIS

TY  - JOUR
TI  - SSGJ-601 versus Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion: 52-Week Results from a Phase 3 Study.
AU  - Wang L
AU  - Li Z
AU  - Ren X
AU  - Tan L
AU  - Zhao S
AU  - Lu Y
AU  - Hao J
AU  - Wu M
AU  - Xu X
AU  - Shi H
AU  - Ren Q
AU  - You Z
AU  - Song Y
AU  - Zhang W
AU  - Lei C
AU  - Zhang X
AU  - Wang X
AU  - Tan W
AU  - Yuan S
AU  - Tao L
AU  - Chen C
AU  - Song Z
AU  - Zhuang W
AU  - Zhang H
AU  - Han Q
AU  - Jin Y
AU  - Peng J
AU  - Zhang Q
AU  - Gao J
AU  - Pan X
AU  - Shen Y
AU  - Li M
AU  - Wang J
AU  - An L
AU  - Liu X
AU  - Li J
AU  - Chen L
AU  - Wang H
AU  - Zhang J
AU  - Zhou Z
AU  - Zhong J
AU  - Wang Y
AU  - Zhang T
AU  - Xiong W
AU  - Cui L
AU  - Peng X
AU  - Yang M
AU  - Zhang M
AU  - Li Z
AU  - Wang H
AU  - Lou J
AU  - Liu Y
AU  - Dai H
AU  - Li X
PY  - 2026
JO  - Ophthalmology. Retina
DO  - 10.1016/j.oret.2026.08.025
UR  - https://doi.org/10.1016/j.oret.2026.08.025
ER  -

APA

L, W., Z, L., X, R., L, T., S, Z., Y, L., J, H., M, W., X, X., H, S., Q, R., Z, Y., Y, S., W, Z., C, L., X, Z., X, W., W, T., S, Y., L, T., C, C., Z, S., W, Z., H, Z., Q, H., Y, J., J, P., Q, Z., J, G., X, P., Y, S., M, L., J, W., L, A., X, L., J, L., L, C., H, W., J, Z., Z, Z., J, Z., Y, W., T, Z., W, X., L, C., X, P., M, Y., M, Z., Z, L., H, W., J, L., Y, L., H, D., & X, L. (2026). SSGJ-601 versus Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion: 52-Week Results from a Phase 3 Study.. Ophthalmology. Retina. https://doi.org/10.1016/j.oret.2026.08.025

Source records

pubmed · retrieved 2026-09-26T03:09:20.852Z